AbbVie: Spondylarthritis trials

The registry lists 25 Spondylarthritis studies with AbbVie as lead sponsor. 1 are open to participants now and 19 have results posted.

Phase 2 1Phase 3 4Phase 4 1No phase 19(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Expanded Access to UpadacitinibAvailableNCT04159597
• A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial SpondyloarthritisCompletedNCT04169373Phase 3Results posted
• A Post-Marketing-Observational Study (PMOS) to Determine the Effectiveness of Combined Adalimumab Treatment and Active Supervised Training in Patients With Axial Spondyloarthritis (axSpA)TerminatedNCT03258814Results posted
• A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine TreatmentTerminatedNCT02897115Phase 4Results posted
• Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)CompletedNCT02750800Results posted
• Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) PatientsCompletedNCT02333383Results posted
• BI 655066 (Risankizumab) Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS)CompletedNCT02047110Phase 2Results posted
• Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in BelgiumCompletedNCT01845818Results posted
• Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial SpondyloarthritisCompletedNCT01808118Phase 3Results posted
• Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical PracticeCompletedNCT01768858Results posted
• Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical PracticeCompletedNCT01754727Results posted
• Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic ArthritisCompletedNCT01474876Results posted
• Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)CompletedNCT01329380Results posted
• Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With AdalimumabCompletedNCT01282372Results posted
• Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With AdalimumabCompletedNCT01273519Results posted
• Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS)CompletedNCT01079182Results posted
• A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )CompletedNCT01078558Results posted
• EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European CountriesCompletedNCT01078402Results posted
• Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA)CompletedNCT01064856Phase 3Results posted
• Study of Adalimumab in Patients With Axial SpondyloarthritisCompletedNCT00939003Phase 3Results posted
• A Study to Investigate the Clinical REsponses in Ankylosing Spondylitis Patients on Adalimumab Therapy in Taiwan (EAST)CompletedNCT03505892
• Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory DiseasesCompletedNCT03339089
• Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health ServiceCompletedNCT03223012
• A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian FederationCompletedNCT02988674
• Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing SpondylitisCompletedNCT01387802